China Resourcesnjiu Medical & Pharmaceutical Co (SZSE:000999) Additional Paid-In Capital : ¥0 Mil(As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is China Resourcesnjiu Medical & Pharmaceutical Co Additional Paid-In Capital?

China Resourcesnjiu Medical & Pharmaceutical Co's quarterly additional paid-in capital increased from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥1,322 Mil) but then stayed the same from Dec. 2023 (¥1,322 Mil) to Mar. 2024 (¥0 Mil).

China Resourcesnjiu Medical & Pharmaceutical Co's annual additional paid-in capital increased from Dec. 2021 (¥1,168 Mil) to Dec. 2022 (¥1,322 Mil) and increased from Dec. 2022 (¥1,322 Mil) to Dec. 2023 (¥1,322 Mil).

China Resourcesnjiu Medical & Pharmaceutical Co Additional Paid-In Capital Historical Data

The historical data trend for China Resourcesnjiu Medical & Pharmaceutical Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resourcesnjiu Medical & Pharmaceutical Co Additional Paid-In Capital Chart

China Resourcesnjiu Medical & Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

1,167.85

1,322.02

1,322.28

China Resourcesnjiu Medical & Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															-	1,309.01	-	1,322.28	-

China Resourcesnjiu Medical & Pharmaceutical Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

China Resourcesnjiu Medical & Pharmaceutical Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of China Resourcesnjiu Medical & Pharmaceutical Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

China Resourcesnjiu Medical & Pharmaceutical Co (SZSE:000999) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Sanjiu Medical & Pharmaceutical Co Ltd (SZSE:000999) » Definitions » Additional Paid-In Capital

Traded in Other Exchanges

N/A

Address

High-Tech Park, Lake Street Mission Hills, Longhua District, Shenzhen, CHN, 518110

Website

http://www.999.com.cn

China Resources Sanjiu Medical & Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in the research and development, production and sale of pharmaceutical products, healthcare products, and medical appliances under the brand name 999, which includes OTC, antibiotic and raw material drug. The other brands under which the company offers its products are Lee King, Shunfeng, and Tianhe. The company's core business is located in OTC and Chinese medicine prescription drugs, OTC core products in the cold, gastrointestinal, skin, pediatric, cough and orthopedic drugs occupy a higher market share; prescription drug products in traditional Chinese medicine formula granules, cardiovascular and cerebrovascular, anti-tumor in the field of anti-infection and other areas.

China Resourcesnjiu Medical & Pharmaceutical Co (SZSE:000999) Headlines

No Headlines